ID   GALT1_BOVIN             Reviewed;         559 AA.
AC   Q07537;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   03-AUG-2022, entry version 160.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 1 {ECO:0000250|UniProtKB:Q10472};
DE            EC=2.4.1.41 {ECO:0000269|PubMed:3082881, ECO:0000269|PubMed:7685345};
DE   AltName: Full=Polypeptide GalNAc transferase 1;
DE            Short=GalNAc-T1;
DE            Short=pp-GaNTase 1;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 1;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1;
DE   Contains:
DE     RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 1 soluble form;
GN   Name=GALNT1 {ECO:0000250|UniProtKB:Q10472};
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 41-74, FUNCTION, CATALYTIC
RP   ACTIVITY, AND PATHWAY.
RC   TISSUE=Colostrum, and Intestine;
RX   PubMed=7685345; DOI=10.1016/s0021-9258(18)31432-7;
RA   Homa F.L., Hollander T., Lehman D.J., Thomsen D.R., Elhammer A.P.;
RT   "Isolation and expression of a cDNA clone encoding a bovine UDP-
RT   GalNAc:polypeptide N-acetylgalactosaminyltransferase.";
RL   J. Biol. Chem. 268:12609-12616(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 41-559, AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Colostrum, and Placenta;
RX   PubMed=8360184; DOI=10.1016/s0021-9258(17)46720-2;
RA   Hagen F.K., van Wuyckhuyse B., Tabak L.A.;
RT   "Purification, cloning, and expression of a bovine UDP-GalNAc: polypeptide
RT   N-acetyl-galactosaminyltransferase.";
RL   J. Biol. Chem. 268:18960-18965(1993).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, PATHWAY, SUBCELLULAR LOCATION,
RP   GLYCOSYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=3082881; DOI=10.1016/s0021-9258(19)57206-4;
RA   Elhammer A., Kornfeld S.;
RT   "Purification and characterization of UDP-N-acetylgalactosamine:
RT   polypeptide N-acetylgalactosaminyltransferase from bovine colostrum and
RT   murine lymphoma BW5147 cells.";
RL   J. Biol. Chem. 261:5249-5255(1986).
RN   [4]
RP   MUTAGENESIS OF ASN-95; HIS-125; HIS-137; ASN-141; HIS-146; HIS-179;
RP   HIS-211; HIS-228; HIS-341; HIS-344; HIS-404; HIS-427; HIS-460; HIS-498;
RP   HIS-499; HIS-517 AND ASN-552.
RX   PubMed=9359852; DOI=10.1042/bj3280193;
RA   Wragg S., Hagen F.K., Tabak L.A.;
RT   "Identification of essential histidine residues in UDP-N-acetyl-D-
RT   galactosamine:polypeptide N-acetylgalactosaminyltransferase-T1.";
RL   Biochem. J. 328:193-197(1997).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide
CC       biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a
CC       serine or threonine residue on the protein receptor (PubMed:3082881,
CC       PubMed:7685345). Has a broad spectrum of substrates such as apomucin-,
CC       MUC5AC-, MUC1- and MUC2-derived peptides (By similarity).
CC       {ECO:0000250|UniProtKB:Q10472, ECO:0000269|PubMed:3082881,
CC       ECO:0000269|PubMed:7685345}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-
CC         [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:3082881, ECO:0000269|PubMed:7685345};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-
CC         O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) +
CC         UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:3082881, ECO:0000269|PubMed:7685345};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:3082881};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:3082881, ECO:0000269|PubMed:7685345}.
CC   -!- SUBCELLULAR LOCATION: [Polypeptide N-acetylgalactosaminyltransferase
CC       1]: Golgi apparatus, Golgi stack membrane {ECO:0000250}; Single-pass
CC       type II membrane protein {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Polypeptide N-acetylgalactosaminyltransferase 1
CC       soluble form]: Secreted {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Colostrum contains a soluble form.
CC       {ECO:0000269|PubMed:3082881}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif), which
CC       is probably involved in manganese coordination and substrate binding
CC       and the C-terminal domain (domain B, also called Gal/GalNAc-T motif),
CC       which is probably involved in catalytic reaction and UDP-Gal binding.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain directs the glycopeptide
CC       specificity. It is required in the glycopeptide specificity of enzyme
CC       activity but not for activity with naked peptide substrates, suggesting
CC       that it triggers the catalytic domain to act on GalNAc-glycopeptide
CC       substrates (By similarity). {ECO:0000250}.
CC   -!- PTM: N-glycosylated, contains two N-linked oligosaccharides.
CC       {ECO:0000269|PubMed:3082881}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L07780; AAA30532.1; -; mRNA.
DR   EMBL; L17437; AAA68489.1; -; mRNA.
DR   PIR; A45987; A45987.
DR   RefSeq; NP_803485.1; NM_177519.3.
DR   RefSeq; XP_010816977.1; XM_010818675.2.
DR   AlphaFoldDB; Q07537; -.
DR   SMR; Q07537; -.
DR   STRING; 9913.ENSBTAP00000014882; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q07537; -.
DR   PaxDb; Q07537; -.
DR   PRIDE; Q07537; -.
DR   Ensembl; ENSBTAT00000014882; ENSBTAP00000014882; ENSBTAG00000011206.
DR   Ensembl; ENSBTAT00000069475; ENSBTAP00000066267; ENSBTAG00000011206.
DR   Ensembl; ENSBTAT00000081582; ENSBTAP00000067739; ENSBTAG00000011206.
DR   GeneID; 282241; -.
DR   KEGG; bta:282241; -.
DR   CTD; 2589; -.
DR   VEuPathDB; HostDB:ENSBTAG00000011206; -.
DR   VGNC; VGNC:29222; GALNT1.
DR   eggNOG; KOG3736; Eukaryota.
DR   GeneTree; ENSGT00940000154732; -.
DR   HOGENOM; CLU_013477_0_1_1; -.
DR   InParanoid; Q07537; -.
DR   OMA; VAEVWMC; -.
DR   OrthoDB; 606683at2759; -.
DR   TreeFam; TF313267; -.
DR   BRENDA; 2.4.1.41; 908.
DR   Reactome; R-BTA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   Proteomes; UP000009136; Chromosome 24.
DR   Bgee; ENSBTAG00000011206; Expressed in thymus and 109 other tissues.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB.
DR   GO; GO:0018242; P:protein O-linked glycosylation via serine; IEA:Ensembl.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; IEA:Ensembl.
DR   CDD; cd02510; pp-GalNAc-T; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR045885; GalNAc-T.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Lectin; Manganese; Membrane;
KW   Metal-binding; Reference proteome; Secreted; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..559
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 1"
FT                   /id="PRO_0000223386"
FT   CHAIN           41..559
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 1
FT                   soluble form"
FT                   /id="PRO_0000012255"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..28
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        29..559
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          431..551
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          45..65
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          115..225
FT                   /note="Catalytic subdomain A"
FT   REGION          285..347
FT                   /note="Catalytic subdomain B"
FT   BINDING         156
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         186
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         209
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         211
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         316
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         344
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         347
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         352
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            141
FT                   /note="Not glycosylated"
FT                   /evidence="ECO:0000305"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:3082881"
FT   CARBOHYD        552
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:3082881"
FT   DISULFID        106..339
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        330..408
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        442..459
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        482..497
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        523..540
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   MUTAGEN         95
FT                   /note="N->Q: Induces decrease in glycosylation."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         125
FT                   /note="H->A: Induces a strong decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         137
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         141
FT                   /note="N->Q: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         146
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         179
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         211
FT                   /note="H->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         228
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         341
FT                   /note="H->A: Induces a strong decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         344
FT                   /note="H->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         404
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         427
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         460
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         498
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         499
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         517
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:9359852"
FT   MUTAGEN         552
FT                   /note="N->Q: Induces decrease in glycosylation."
FT                   /evidence="ECO:0000269|PubMed:9359852"
SQ   SEQUENCE   559 AA;  64192 MW;  E3E538C4DE569B40 CRC64;
     MRKFAYCKVV LATSLIWVLL DMFLLLYFSE CNKCDEKKER GLPAGDVLEP VQKPHEGPGE
     MGKPVVIPKE DQEKMKEMFK INQFNLMASE MIALNRSLPD VRLEGCKTKV YPDNLPTTSV
     VIVFHNEAWS TLLRTVHSVI NRSPRHMLEE IVLVDDASER DFLKRPLESY VKKLKVPVHV
     IRMEQRSGLI RARLKGAAVS KGQVITFLDA HCECTVGWLE PLLARIKHDR KTVVCPIIDV
     ISDDTFEYMA GSDMTYGGFN WKLNFRWYPV PQREMDRRKG DRTLPVRTPT MAGGLFSIDR
     DYFQEIGTYD AGMDIWGGEN LEISFRIWQC GGTLEIVTCS HVGHVFRKAT PYTFPGGTGQ
     IINKNNRRLA EVWMDEFKNF FYIISPGVTK VDYGDISSRL GLRHKLQCRP FSWYLENIYP
     DSQIPRHYFS LGEIRNVETN QCLDNMARKE NEKVGIFNCH GMGGNQVFSY TANKEIRTDD
     LCLDVSKLNG PVTMLKCHHL KGNQLWEYDP VKLTLQHVNS NQCLDKATDE DSQVPSIRDC
     SGSRSQQWLL RNVTLPEIF
//
